| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 08/07/2013 | CN103232542A Double-target chimeric protein |
| 08/07/2013 | CN102443594B Receptor activator of nuclear factor kappa B ligand (RANKL)-HBaAg expression constructing object, yeast, manufacture method as well as application |
| 08/06/2013 | US8501189 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases |
| 08/06/2013 | CA2844264A1 Optimized antigens of pneumocystis and use thereof |
| 08/06/2013 | CA2529660C Vegf traps and therapeutic uses thereof |
| 08/06/2013 | CA2371929C Fab'-epitope complex from the hiv-1 cross-neutralizing monoclonal antibody 2f5 |
| 08/01/2013 | WO2013112986A1 Fusion proteins comprising igg2 hinge domains |
| 08/01/2013 | WO2013110824A1 Multi-component chimera for use as a vaccine against infection by leishmania spp. in mammals |
| 08/01/2013 | WO2013110163A1 Compositions and methods of modulating an immune response |
| 08/01/2013 | WO2013048222A3 Peptide for synthesizing silica, and use thereof |
| 08/01/2013 | US20130196433 Boronate-Mediated Delivery of Molecules into Cells |
| 08/01/2013 | US20130196376 Method for the High Level Expression of Active Lymphotoxin-Beta Receptor Immunoglobulin Chimeric Proteins and Their Purification |
| 08/01/2013 | DE102010051895B4 Chemokinkonjugat zur Sichtbarmachung von Tumoren Chemokinkonjugat for the visualization of tumors |
| 07/31/2013 | EP2620453A1 FUSION PROTEIN SAmB, CODING GENE AND APPLICATION THEREOF |
| 07/31/2013 | EP2620452A1 Binding members for IGE molecules |
| 07/31/2013 | EP2619229A2 Multimeric il-15 soluble fusion molecules and methods of making and using same |
| 07/31/2013 | CN103224563A Application of synthetic transcription factor VP64-Os01g63510 |
| 07/31/2013 | CN102659926B Pc-E polypeptide inhibiting aspergillus fumigatus from adhering to cornea |
| 07/31/2013 | CN102633884B Bacillus thuringiensis vip1like1/vip2like1 gene combination and application thereof |
| 07/31/2013 | CN102617738B Polypeptides, coding sequences, preparation method and use of recombinant fusion protein CLD |
| 07/31/2013 | CN102584949B Pc-C polypeptide inhibiting aspergillus fumigatus from adhering to cornea |
| 07/31/2013 | CN102558360B Trypsin inhibitor and preparation method and application thereof |
| 07/31/2013 | CN102321178B Novel gonadotropin releasing hormone oriented fusion protein mutant |
| 07/31/2013 | CN102206660B Engineered protein TAT-VP28 against white spot syndrome virus of shrimp and its preparation and purpose |
| 07/31/2013 | CN102040653B Tag peptide capable of realizing affinity binding with polystyrene and method for preparing enzyme-linked immuno solid phase antigen with same |
| 07/31/2013 | CN101117635B Fusion expression of PTD,HIF ODD and tumour inhibitory gene and uses thereof |
| 07/30/2013 | US8497118 Chimeric immunoreceptor useful in treating human cancers |
| 07/30/2013 | CA2691091C Fusion protein, macromolecule assembled from the fusion protein, and its use in the prevention or treatment of human papillomavirus related diseases |
| 07/30/2013 | CA2523101C Cleavage of fusion proteins using granzyme b protease |
| 07/30/2013 | CA2513213C Albumin fusion proteins |
| 07/25/2013 | WO2013109927A2 Metallodrugs having improved pharmacological properties and methods of manufacture and use thereof |
| 07/25/2013 | WO2013109904A1 Compositions, methods and kits for treatment of cancer and autoimmune diseases |
| 07/25/2013 | WO2013107388A1 Interferon and immune globulin fc section fusion protein |
| 07/25/2013 | WO2013106909A1 Novel peptides and methods and uses thereof for preventing retinal disorders |
| 07/25/2013 | US20130190477 Complement receptor 2 (cr2) targeting groups |
| 07/25/2013 | US20130189735 Process for engineering polyvalent, polyspecific fusion proteins using uteroglobin as skeleton and so obtained products. |
| 07/25/2013 | US20130189712 T2r, a novel family of taste receptors |
| 07/25/2013 | US20130189287 Enzymatic conjugation of polypeptides |
| 07/25/2013 | US20130189254 Inhibition of AXL/GAS6 Signaling in the Treatment of Disease |
| 07/25/2013 | DE102011057183A1 Neue organisch-anorganische Kompositmaterialien durch Biomineralisation New organic-inorganic composite materials by biomineralization |
| 07/24/2013 | EP2616537A2 Methods and compositions for the extracellular transport of biosynthetic hydrocarbons and other molecules |
| 07/24/2013 | EP2616485A2 Step-derived peptide for brain injury treatment |
| 07/24/2013 | CN1853730B Modified cytokines for use in cancer therapy |
| 07/24/2013 | CN103221425A Fusion proteins comprising antigenic APOB-00 protein fragments and a protein carrier, related compositions, methods and systems for treatment and/or prevention of atherosclerosis |
| 07/24/2013 | CN103221424A Recombinant T-cell receptor ligands with covalently bound peptides |
| 07/24/2013 | CN103215293A Nogo受体拮抗剂 Nogo receptor antagonist |
| 07/24/2013 | CN103215290A Insect-resistant fusion gene as well as insect-resistant fusion protein and application of insect-resistant fusion gene and insect-resistant fusion protein |
| 07/24/2013 | CN103214584A Fusion protein with double functions of inhibiting revascularization of tumor microenvironment and activating adaptive immune response, and gene and application thereof |
| 07/24/2013 | CN103214583A Secretory expression method of bacteriocin lacticin Q |
| 07/24/2013 | CN103214582A Immunogenic fusion protein for tuberculosis and application of immunogenic fusion protein |
| 07/24/2013 | CN103214581A Application of synthetic transcription factor VP64-Os03g57670 |
| 07/24/2013 | CN103214580A Anti Her2 immune cytokine and application thereof |
| 07/24/2013 | CN103214579A Animal fusion recombinant interferon |
| 07/24/2013 | CN103214554A Mucosal immunoadjuvant inducing Th1 immune response, and application thereof |
| 07/24/2013 | CN103212084A IgG FC fragment for a drug carrier and method for the preparation thereof |
| 07/24/2013 | CN102120773B Dual specificity antibodies and methods of making and using |
| 07/24/2013 | CN101993495B Protein mixture and preparation method thereof |
| 07/24/2013 | CN101942022B Anti-human epidermal growth factor receptor single-chain antibody-ferritin heavy chain subunit protein and construction method and application thereof |
| 07/24/2013 | CN101484472B Improved sgp130Fc dimers |
| 07/24/2013 | CN101454347B Influenza antigens, vaccine compositions, and related methods |
| 07/24/2013 | CN101384623B Process for the production of preformed conjugates of albumin and a therapeutic agent |
| 07/23/2013 | US8492613 GNTIII expression in plants |
| 07/23/2013 | US8492118 Fusion molecules and IL-15 variants |
| 07/23/2013 | US8491906 Selective targeting of tumor vasculature using antibody molecules |
| 07/23/2013 | CA2529583C Oxidoreductase from pichia capsulata |
| 07/23/2013 | CA2438886C Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture |
| 07/23/2013 | CA2428114C Apolipoprotein analogues |
| 07/18/2013 | WO2013106643A2 Compounds & methods for the enhanced degradation of targeted proteins & other polypeptides by an e3 ubiquitin ligase |
| 07/18/2013 | WO2013106489A1 Humanized antibodies with ultralong cdr3s |
| 07/18/2013 | WO2012165737A9 Cell-penetrating fusion protein for regenerating or proliferating stem cell |
| 07/18/2013 | US20130184438 Mutant protein |
| 07/18/2013 | US20130183712 Method and compositions for the detection of protein glycosylation |
| 07/18/2013 | US20130183377 Synthetic immunogen useful for generating long lasting immunity and protection against pathogens |
| 07/17/2013 | EP2615116A1 Peptide having the ability to regenerate bone tissue and for binding to apatite |
| 07/17/2013 | EP2614072A2 Human cytomegalovirus vaccine |
| 07/17/2013 | CN103209701A Immunogenic vaccine |
| 07/17/2013 | CN103205370A Hybrid antibacterial peptide pichia pastoris engineering bacteria and preparation method thereof |
| 07/17/2013 | CN103204945A Eukaryotic expression CFP10-ESAT-6 fusion protein for diagnosis of bovine tuberculosis |
| 07/17/2013 | CN103204944A Long-acting immune fusion protein for treating diabetes mellitus |
| 07/17/2013 | CN103204943A Fusion protein of RSV (respiratory syncytial virus) protein F and Fc, and application thereof |
| 07/17/2013 | CN103204942A Porcine circovirus type II gene engineering subunit vaccine, and preparation method and application thereof |
| 07/17/2013 | CN103204941A Methods and compositions using FGF23 fusion polypeptide |
| 07/17/2013 | CN103204940A CD147-5A12MAb compound crystal structure and application thereof |
| 07/17/2013 | CN103204939A CD147-HAb18MAb compound crystal structure and application thereof |
| 07/17/2013 | CN103204938A Hybrid antibacterial peptide LFB_Mel and preparation method thereof |
| 07/17/2013 | CN103203016A Cat Allergen Fusion Proteins And Uses Thereof |
| 07/17/2013 | CN101903404B Bivalent, bispecific antibodies |
| 07/16/2013 | US8486647 Neuropeptide release assay for sodium channels |
| 07/16/2013 | CA2516834C Polypeptides and methods for making the same |
| 07/16/2013 | CA2512138C Kim-1 antagonists and use to modulate immune system |
| 07/16/2013 | CA2448348C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/16/2013 | CA2395406C Method for treating inflammation |
| 07/11/2013 | WO2013102265A1 Compositions and methods for treating multiple sclerosis |
| 07/11/2013 | WO2013102264A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| 07/11/2013 | WO2013013105A3 Compositions and methods for re-programming cells without genetic modification for repairing cartilage damage |
| 07/11/2013 | US20130178418 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 07/11/2013 | US20130177558 Method of Treating Immunological Disorders by Administering Truncated BAFF Receptors |
| 07/10/2013 | EP2611827A1 Recombinant t-cell receptor ligands with covalently bound peptides |
| 07/10/2013 | EP2611826A1 Method and composition for crystallizing a family c gpcr |
| 07/10/2013 | EP2611823A1 Peptide containing multiple n-linked glycosylation sequons |